Companion Medical, makers of the first FDA approved smart insulin pen, recently announced their Bluetooth-enabled InPen is now available in retail pharmacies nationwide. These smart pens offer a variety of benefits with very few downsides.
read more →
There’s only one goal for kids heading off to camp – FUN. But the added perks at diabetes camp can have life-long effects: independence, self-esteem, and the opportunity to finally feel normal.
read more →
Reflecting on her six year anniversary of living with diabetes, Sarah Durrand shares the hardest lessons, the most meaningful lessons, and the lessons she’s learned that give her the best excuse to eat pizza (sometimes).
read more →
Eating disorders among adolescent and young adult women with diabetes are twice as high as in their non-diabetic peers, but it’s still not a widely discussed issue. Former ADA youth spokesman Quinn Nystrom speaks openly about her struggle with an eating disorder after her type 1 diagnosis.
read more →
Evidence-based hope is letting people know that things are different than they were even 20 years ago. We now know that that with well-managed type 1 or type 2 diabetes, the odds are good you’re going to live a long and healthy life.
read more →
If you or your spouse has diabetes, what are the chances your children will also develop the disease? Dr. David Greene (who lives with type 1) did the research, and some of it may surprise you.
read more →
Diabetes Clinician Nalani Haviland, who also has lived with type 1 diabetes for over 2o years, shares her recent experience with the implantable Eversense CGM.
read more →
The A1c test has been around for a long time and is supposed to give people an idea of what their average glucose value has been over the prior two to three months, but there are many situations where the A1c is not accurate.
read more →
TrialNet is an international network of leading academic institutions, physicians, scientists and healthcare teams dedicated to the prevention of type 1 diabetes. They offer risk screening for relatives of people with type 1 diabetes and innovative clinical studies to preserve insulin production.
read more →
A new oral medication for T1D is awaiting FDA approval, and it’s shown fewer highs, fewer lows, and more predictable insulin dosing in recent studies.
read more →
